Ivermectin long acting injectable (Medincell)

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameIvermectin long acting injectable (Medincell)
Drug Alias Namemdc-STMmdc-TTG
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate-gated chloride channel modulators
TargetsGlutamate-gated chloride channel
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedincell SA
China Registration ClassN/A

Develop Information

Active CompaniesMedincell SA
Inactive CompaniesN/A
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A